Durvalumab/tremelimumabSkin pruritus, autoimmune myocarditis and myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1710卷 / 1期

关键词：

D O I：

10.1007/s40278-018-48799-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：126 / 126

相关论文

共 50 条

[1] Atorvastatin/durvalumab/rosuvastatinMyopathy, myositis and myocarditis: case report
Reactions Weekly, 2021, 1843 (1) : 62 - 62
[2] Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
Jason Cham
Daniel Ng
Laura Nicholson
Journal of Medical Case Reports, 15
[3] Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
Cham, Jason
Ng, Daniel
Nicholson, Laura
JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
[4] PembrolizumabOphthalmoplegia, myositis and myocarditis : case report
Reactions Weekly, 2018, 1691 (1) : 215 - 215
[5] PembrolizumabFatal myositis and myocarditis: case report
Reactions Weekly, 2019, 1764 (1) : 267 - 267
[6] NivolumabAutoimmune myocarditis and myositis: case report
Reactions Weekly, 2016, 1632 (1) : 228 - 228
[7] CemiplimabMyasthenia gravis, myocarditis and myositis: case report
Reactions Weekly, 2020, 1818 (1) : 79 - 79
[8] Epacadostat/pembrolizumabFatal myocarditis and myositis: case report
Reactions Weekly, 2019, 1764 (1) : 126 - 126
[9] Ipilimumab/nivolumabAcute myocarditis and myositis: case report
Reactions Weekly, 2017, 1654 (1) : 194 - 194
[10] NivolumabMyasthenia gravis, myositis and myocarditis: case report
Reactions Weekly, 2022, 1897 (1) : 291 - 291

← 1 2 3 4 5 →